Alfaro, Jackie Mae .
HRN: 13-52-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2022
CEFUROXIME 1.5GM (VIAL)
07/29/2022
07/31/2022
IV
1.5gm
Q8 X 7 Doses
S/P Repeat LTCS For Placenta Previa
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes